GO:0016175 superoxide-generating NAD(P)H oxidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016175 describes the enzymatic activity that catalyzes NAD(P)H + O2 = NAD(P)H + O2-, producing superoxide anion.
• The activity is carried by NADPH oxidase (NOX) complexes, including NOX1, NOX2 (gp91phox), NOX4, NOX5 and their regulatory subunits such as p22phox, p47phox, p67phox and Rac.
• Superoxide generated by this activity is a primary reactive oxygen species signal in ventilatory muscle, skeletal muscle, colon epithelium, and vascular tissue.
• Dysregulated superoxide-generating NAD(P)H oxidase activity contributes to chronic granulomatous disease, doxorubicin cardiotoxicity, hypertension, and cardiovascular disease.
• Key experimental models include knockout, point-mutation, knock-in, and overexpression cell lines, plus CRISPR library screening for pathway discovery.
• EDITGENE provides end-to-end CRISPR services to interrogate GO:0016175-related genes in disease and physiology.
Description
Superoxide-generating NAD(P)H oxidase activity (GO:0016175) is a molecular function that catalyzes the one-electron reduction of molecular oxygen to superoxide anion using NADH or NADPH as the electron donor. This activity is the defining catalytic property of the NOX family of enzymes, which are membrane-bound flavocytochromes that transfer electrons from cytosolic NAD(P)H across biological membranes to oxygen. The reaction is central to both host defense and redox signaling, and its dysregulation is implicated in a wide range of pathologies. Researchers study GO:0016175 because superoxide produced by this activity acts as a second messenger in normal physiology and as a damaging oxidant in disease. In ventilatory muscles, a superoxide-generating NAD(P)H oxidase was molecularly characterized and shown to contribute to basal and stimulated superoxide production. In contracting skeletal muscle, NAD(P)H oxidases are now recognized as major contributors to superoxide formation, redefining earlier assumptions about mitochondrial sources. In colon epithelial cells, proteins homologous to p47phox and p67phox support superoxide production by NOX1, demonstrating tissue-specific regulatory mechanisms. The activity is also a therapeutic target. Gp91phox-containing NAD(P)H oxidase increases superoxide formation in the presence of doxorubicin and NADPH, linking this activity to chemotherapy-induced cardiotoxicity. Gene therapy approaches for chronic granulomatous disease aim to restore this activity in phagocytes. In the vasculature, NOX5-derived superoxide is implicated in hypertension and cardiovascular disease. Thus, GO:0016175 sits at the intersection of immunity, redox biology, and cardiovascular medicine.
superoxide-generating NAD(P)H oxidase activity At A Glance
| GO ID | GO:0016175 |
|---|---|
| GO term | superoxide-generating NAD(P)H oxidase activity |
| Ontology | molecular_function |
| Synonym | cytochrome B-245 |
| Definition | Catalysis of the reaction: NAD(P)H + O2 = NAD(P)H + O2-. |
| Major function | Production of superoxide anion for host defense and redox signaling |
| Representative enzymes | NOX1, NOX2 (gp91phox), NOX4, NOX5, and associated subunits |
| Cofactors | FAD, heme, and NAD(P)H |
| Regulatory subunits | p22phox, p47phox, p67phox, Rac |
What Is GO:0016175?
In simple terms, GO:0016175 is the enzyme activity that takes electrons from NADH or NADPH and hands them to oxygen, creating superoxide (O2-). The official definition is: Catalysis of the reaction: NAD(P)H + O2 = NAD(P)H + O2-. This activity is synonymous with cytochrome B-245 and is a molecular function. It is the catalytic core of NADPH oxidase complexes, which are multi-subunit enzymes that assemble at membranes to produce superoxide.
Why Is superoxide-generating NAD(P)H oxidase activity Important in Cell Biology?
GO:0016175 is important because superoxide generated by NADPH oxidases is a double-edged sword: it is essential for microbial killing in phagocytes, but when overproduced it drives oxidative stress, inflammation, and tissue injury. The activity is a validated drug target in cardiovascular disease, and its genetic defects cause chronic granulomatous disease. Understanding its regulation and tissue-specific composition is therefore critical for both basic redox biology and translational medicine.
• Defects in the phagocyte NADPH oxidase cause chronic granulomatous disease, characterized by recurrent infections.
• Gp91phox-containing NAD(P)H oxidase contributes to doxorubicin-induced superoxide formation and cardiotoxicity.
• NOX5-generated superoxide is implicated in hypertension and cardiovascular disease.
• NAD(P)H oxidases are major sources of superoxide in contracting skeletal muscle, affecting exercise adaptation.
• In ventilatory muscles, this activity modulates redox balance and fatigue.
• Colon epithelial cells use NOX1 with p47phox/p67phox homologs for superoxide production, impacting mucosal defense.
• The activity is a source of reactive oxygen species that modulate cell proliferation, migration, and apoptosis.
• It is a target for gene therapy in chronic granulomatous disease.
• Pharmacological inhibition of NOX enzymes is being explored for cardiovascular and fibrotic diseases.
• CRISPR screening can identify novel regulators of GO:0016175 in disease models.
Mechanism, Genes and Research Methods
Electron Transfer and Superoxide Formation
In simple terms: The enzyme grabs electrons from NADPH and gives them to oxygen, making superoxide.
The catalytic cycle of superoxide-generating NAD(P)H oxidase begins with binding of NADPH or NADH to the dehydrogenase domain of the NOX protein. Electrons are transferred via FAD to two heme groups in the transmembrane domain, and finally to molecular oxygen on the extracellular or luminal side, producing superoxide anion. This vectorial electron transfer is unique among oxidoreductases and allows superoxide to be generated in specific compartments.
Assembly of the Multisubunit Complex
In simple terms: Several proteins must come together for the enzyme to work.
For NOX2 (gp91phox), activation requires assembly with p22phox, p47phox, p67phox, p40phox, and Rac. In colon epithelial cells, NOX1 uses proteins homologous to p47phox and p67phox to support superoxide production. The assembly is triggered by phosphorylation and membrane recruitment, ensuring tight spatial and temporal control.
Tissue-Specific Isoforms and Regulation
In simple terms: Different tissues use different versions of the enzyme.
NOX1, NOX2, NOX4, and NOX5 exhibit distinct tissue distributions and regulatory mechanisms. In ventilatory muscles, a superoxide-generating NAD(P)H oxidase was molecularly characterized, showing unique subunit composition. In skeletal muscle, NAD(P)H oxidases are major contributors to superoxide production during contraction, with NOX2 and NOX4 being prominent. Vascular smooth muscle expresses NOX5, which is activated by calcium and contributes to hypertension.
Pathophysiological Consequences
In simple terms: Too much superoxide from this enzyme can damage tissues.
Excessive superoxide production by NAD(P)H oxidases leads to oxidative stress, endothelial dysfunction, and inflammation. Gp91phox-containing NAD(P)H oxidase increases superoxide formation in the presence of doxorubicin, contributing to cardiotoxicity. In chronic granulomatous disease, loss of this activity impairs bacterial killing. In the vasculature, NOX5-derived superoxide promotes hypertension and cardiovascular remodeling.
Key Genes Involved in GO:0016175 superoxide-generating NAD(P)H oxidase activity
The following genes encode the catalytic and regulatory subunits of superoxide-generating NAD(P)H oxidase complexes, as well as related proteins studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYBB (NOX2, gp91phox) | Catalytic subunit of phagocyte NADPH oxidase | Mutations cause chronic granulomatous disease; target for gene therapy |
| CYBA (p22phox) | Membrane subunit stabilizing NOX2 and NOX1 | Essential for enzyme maturation and activity |
| NCF1 (p47phox) | Cytosolic organizer subunit | Defects cause autosomal recessive CGD; regulates NOX1 in colon |
| NCF2 (p67phox) | Cytosolic activator subunit | Required for electron transfer; homologs support NOX1 activity |
| NCF4 (p40phox) | Cytosolic subunit modulating phagosomal ROS | Regulates NOX2 activity in neutrophils |
| RAC1 | Small GTPase activator | Binds to NOX1 and NOX2 to enable assembly |
| RAC2 | Hematopoietic GTPase | Critical for NOX2 activation in phagocytes |
| NOX1 | Catalytic subunit in colon and smooth muscle | Uses p47phox/p67phox homologs for superoxide production |
| NOX4 | Constitutively active catalytic subunit | Major source of superoxide in skeletal muscle and kidney |
| NOX5 | Calcium-activated catalytic subunit | Implicated in hypertension and cardiovascular disease |
| DUOX1 | Dual oxidase with peroxidase domain | Superoxide generation in airway epithelium |
| DUOX2 | Dual oxidase in thyroid and gut | Host defense and hormone synthesis |
| NOXO1 | NOX organizer 1 | Homolog of p47phox supporting NOX1 |
| NOXA1 | NOX activator 1 | Homolog of p67phox supporting NOX1 |
| SOD1 | Superoxide dismutase 1 | Converts superoxide to hydrogen peroxide; balances NOX output |
| SOD2 | Mitochondrial superoxide dismutase | Mitigates mitochondrial superoxide; cross-talk with NOX |
| SOD3 | Extracellular superoxide dismutase | Regulates extracellular superoxide from NOX enzymes |
| AKT1 | Kinase regulating NOX activation | Phosphorylates p47phox and modulates assembly |
How Is superoxide-generating NAD(P)H oxidase activity Regulated?
Superoxide-generating NAD(P)H oxidase activity is tightly regulated at multiple levels. NOX2 requires assembly with cytosolic subunits (p47phox, p67phox, p40phox, Rac) upon phosphorylation by protein kinases such as PKC and Akt. NOX1 is regulated by NOXO1 and NOXA1, which are homologs of p47phox and p67phox, and is constitutively active in some colon epithelial cells. NOX4 is constitutively active and regulated primarily by expression levels, while NOX5 is activated by calcium binding to its EF-hand domains. In skeletal muscle, contraction-induced superoxide production by NAD(P)H oxidases is modulated by mechanical strain and calcium signaling. In ventilatory muscles, the activity is influenced by neural drive and fatigue. Additionally, doxorubicin can enhance gp91phox-dependent superoxide formation, indicating pharmacological regulation.
superoxide-generating NAD(P)H oxidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYBB | Chronic granulomatous disease | Knockout iPSC-derived phagocytes; knock-in of patient mutations |
| NCF1 | Chronic granulomatous disease; colon inflammation | Point-mutation knock-in mice; colon epithelial KO |
| NOX5 | Hypertension and cardiovascular disease | Overexpression in vascular smooth muscle cells; KO rats |
| NOX1 | Colon cancer and mucosal defense | Colon epithelial KO; CRISPR library screening |
| NOX4 | Skeletal muscle adaptation and fibrosis | Muscle-specific KO; overexpression in myotubes |
Chronic Granulomatous Disease
Chronic granulomatous disease (CGD) is caused by mutations in genes encoding the phagocyte NADPH oxidase complex, including CYBB, CYBA, NCF1, NCF2, and NCF4. Loss of superoxide-generating NAD(P)H oxidase activity impairs the ability of phagocytes to kill bacteria and fungi, leading to recurrent severe infections and granuloma formation. Gene therapy approaches aim to restore this activity by introducing functional copies of the defective gene into hematopoietic stem cells.
Doxorubicin-Induced Cardiotoxicity
Doxorubicin, a widely used chemotherapy agent, increases superoxide formation by gp91phox-containing NAD(P)H oxidase in the presence of NADPH. This enhanced activity contributes to oxidative stress in cardiomyocytes and is implicated in doxorubicin-induced heart failure. Targeting this activity may reduce cardiotoxicity while preserving antitumor efficacy.
Hypertension and Cardiovascular Disease
NOX5 is a calcium-activated NADPH oxidase expressed in vascular smooth muscle and endothelial cells. Its superoxide-generating activity contributes to endothelial dysfunction, vascular remodeling, and hypertension. NOX1 and NOX2 also play roles in angiotensin II-induced hypertension and atherosclerosis. Inhibitors of NOX enzymes are being investigated as cardiovascular therapeutics.
Neuroinflammation and Neurodegeneration
Fasting-mimicking diet cycles reduce neuroinflammation and attenuate cognitive decline in Alzheimer's models, in part by modulating oxidative stress pathways that include NADPH oxidases. Although the exact contribution of GO:0016175 to neurodegeneration is still being defined, superoxide from microglial NOX2 is thought to promote neuronal damage.
From superoxide-generating NAD(P)H oxidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NOX2 abolish phagocyte superoxide production? | CYBB knockout in HL-60 or iPSC-derived neutrophils |
| How does a patient mutation affect enzyme assembly? | Point-mutation knock-in of CYBB or NCF1 in cell lines |
| Can a tagged NOX1 reveal subcellular localization? | Knock-in of fluorescent tag (e.g., GFP) at endogenous NOX1 locus |
| Does NOX5 overexpression drive hypertension? | Overexpression of NOX5 in vascular smooth muscle cells or transgenic mice |
| Which genes regulate NOX1 activity in colon? | CRISPR library screening in colon epithelial cells |
| Is p47phox phosphorylation required for NOX2 activation? | Point mutations at phosphorylation sites (e.g., S303A, S304A) in NCF1 |
How to Study the superoxide-generating NAD(P)H oxidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lucigenin chemiluminescence | Superoxide production in cell lysates | Quantifying NADPH oxidase activity in tissues |
| Cytochrome c reduction | Extracellular superoxide release | Measuring NOX2 activity in phagocytes |
| Electron spin resonance (ESR) | Direct detection of superoxide radicals | Validating superoxide identity in muscle |
| DHE HPLC | Intracellular superoxide-specific oxidation products | Assessing oxidative stress in cells |
| CRISPR knockout | Loss-of-function of NOX genes | Determining essential subunits for activity |
| CRISPR knock-in | Tagged or mutant NOX proteins | Tracking localization and assembly |
| RNA-seq | Expression of NOX isoforms and regulators | Tissue-specific profiling |
| Proteomics | Protein interactions and modifications | Identifying novel regulators |
Measuring Superoxide Production
Superoxide generation by GO:0016175 is commonly measured using lucigenin- or luminol-enhanced chemiluminescence, cytochrome c reduction, or electron spin resonance (ESR) with spin traps. These assays can be performed in cell lysates, intact cells, or isolated membrane fractions. For real-time detection, fluorescent probes such as dihydroethidium (DHE) and MitoSOX are used, with HPLC-based separation to distinguish superoxide-specific products.
Genetic Manipulation and CRISPR Screening
CRISPR-Cas9 knockout, point mutation, knock-in, and overexpression models enable precise interrogation of genes encoding NOX subunits and regulators. Pooled CRISPR libraries can screen for modifiers of superoxide production using FACS-based reporters or survival assays under oxidative stress. These approaches have identified novel regulators of NOX1 in colon epithelial cells and can be adapted to other tissues.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics reveal expression patterns of NOX isoforms and their regulatory subunits across tissues and disease states. In skeletal muscle, RNA-seq has shown differential expression of NOX2 and NOX4 after exercise. Proteomic analysis of NADPH oxidase complexes can identify post-translational modifications and interacting partners, as demonstrated for p47phox and p67phox homologs in colon cells.
Imaging and Subcellular Localization
Fluorescence microscopy with tagged NOX subunits (e.g., GFP-NOX2, mCherry-p22phox) allows visualization of enzyme assembly and trafficking. Live-cell imaging can track superoxide production using targeted fluorescent probes. These methods have been used to study NOX5 localization in vascular cells and NOX2 assembly in phagocytes.
How CRISPR Can Be Used to Study GO:0016175 superoxide-generating NAD(P)H oxidase activity
Knockout
CRISPR knockout of CYBB, CYBA, NCF1, NCF2, or NOX isoforms abolishes or reduces superoxide-generating NAD(P)H oxidase activity, providing a clean background to study subunit requirements. For example, CYBB knockout in iPSC-derived phagocytes models chronic granulomatous disease and validates gene therapy approaches. Knockout of NOX1 in colon epithelial cells reduces superoxide production and alters mucosal defense.
Point Mutation
Point mutations can mimic patient variants or disrupt phosphorylation sites. For instance, knock-in of the NCF1 S303A/S304A mutations prevents p47phox phosphorylation and impairs NOX2 assembly. Similarly, point mutations in CYBB that cause CGD can be introduced into cell lines to study enzyme stability and function.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) at endogenous NOX loci allows real-time imaging of enzyme trafficking and assembly. Tagged p22phox or NOX2 can reveal membrane localization and interaction dynamics. Knock-in of disease-relevant mutations into NOX5 or CYBB provides isogenic models for drug testing.
Overexpression
Overexpression of NOX5 or NOX1 in vascular smooth muscle cells increases superoxide production and recapitulates features of hypertension. Overexpression of gp91phox in cardiomyocytes enhances doxorubicin-induced superoxide formation, modeling cardiotoxicity. These models are useful for testing NOX inhibitors and antioxidant therapies.
How EDITGENE Supports superoxide-generating NAD(P)H oxidase activity Research
Researchers studying superoxide-generating NAD(P)H oxidase activity-related genes often need to determine whether a candidate gene is causally involved in superoxide production, subunit assembly, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of GO:0016175-related genes.
Contact EDITGENE today to design your custom CRISPR model for superoxide-generating NAD(P)H oxidase activity research.
Frequently Asked Questions About superoxide-generating NAD(P)H oxidase activity
What is superoxide-generating NAD(P)H oxidase activity?
It is the enzyme activity defined by GO:0016175 that catalyzes the reaction NAD(P)H + O2 = NAD(P)H + O2-, producing superoxide anion.
What genes are involved in superoxide-generating NAD(P)H oxidase activity?
Key genes include CYBB (NOX2), CYBA (p22phox), NCF1 (p47phox), NCF2 (p67phox), NCF4 (p40phox), RAC1, RAC2, NOX1, NOX4, NOX5, DUOX1, and DUOX2.
Which diseases are linked to superoxide-generating NAD(P)H oxidase activity?
Chronic granulomatous disease, doxorubicin-induced cardiotoxicity, hypertension, cardiovascular disease, and neuroinflammation are linked to this activity.
How is superoxide-generating NAD(P)H oxidase activity measured?
Common methods include lucigenin chemiluminescence, cytochrome c reduction, electron spin resonance, and DHE HPLC.
What is the role of NOX2 in superoxide production?
NOX2 (gp91phox) is the catalytic subunit of the phagocyte NADPH oxidase, essential for microbial killing; its deficiency causes chronic granulomatous disease.
Can CRISPR be used to study superoxide-generating NAD(P)H oxidase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of NOX genes and their regulators.
What is the difference between NOX1 and NOX5?
NOX1 is regulated by NOXO1 and NOXA1 and is expressed in colon and smooth muscle, while NOX5 is calcium-activated and implicated in hypertension.
How does doxorubicin affect NADPH oxidase activity?
Doxorubicin increases superoxide formation by gp91phox-containing NAD(P)H oxidase in the presence of NADPH, contributing to cardiotoxicity.
Are there tissue-specific differences in superoxide-generating NAD(P)H oxidase activity?
Yes, ventilatory muscles, skeletal muscle, colon epithelium, and vascular tissue express distinct NOX isoforms and regulatory subunits.
What experimental models are available for studying this activity?
Knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening, are widely used.
Conclusion
Superoxide-generating NAD(P)H oxidase activity (GO:0016175) is a fundamental enzymatic function that bridges host defense, redox signaling, and disease. Its catalytic mechanism, subunit composition, and tissue-specific regulation have been elucidated through decades of research, revealing its central role in chronic granulomatous disease, cardiotoxicity, hypertension, and neuroinflammation. Continued investigation using CRISPR-based models will uncover new therapeutic opportunities targeting this activity.
References
- 1. Javeshghani D et al.. 2002. Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles.. Am J Respir Crit Care Med 165(3):412-8 PMID: 11818330
- 2. Rangan P et al.. 2022. Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer's models.. Cell Rep 40(13):111417 PMID: 36170815
- 3. Deng S et al.. 2007. Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH.. Free Radic Biol Med 42(4):466-73 PMID: 17275678
- 4. Sakellariou GK et al.. 2014. Redefining the major contributors to superoxide production in contracting skeletal muscle. The role of NAD(P)H oxidases.. Free Radic Res 48(1):12-29 PMID: 23915064
- 5. Geiszt M et al.. 2003. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells.. J Biol Chem 278(22):20006-12 PMID: 12657628
- 6. Barese CN et al.. 2004. Gene therapy for chronic granulomatous disease.. Expert Opin Biol Ther 4(9):1423-34 PMID: 15335310
- 7. Vignais PV. 2002. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism.. Cell Mol Life Sci 59(9):1428-59 PMID: 12440767
- 8. Touyz RM et al.. 2019. Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease.. Antioxid Redox Signal 30(7):1027-1040 PMID: 30334629
